162 related articles for article (PubMed ID: 19470686)
1. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression.
Glover M; Zuber AM; O'Shaughnessy KM
J Am Soc Nephrol; 2009 Jun; 20(6):1314-22. PubMed ID: 19470686
[TBL] [Abstract][Full Text] [Related]
2. WNK3 and WNK4 amino-terminal domain defines their effect on the renal Na+-Cl- cotransporter.
San-Cristobal P; Ponce-Coria J; Vázquez N; Bobadilla NA; Gamba G
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1199-206. PubMed ID: 18701621
[TBL] [Abstract][Full Text] [Related]
3. Similar effects of all WNK3 variants on SLC12 cotransporters.
Cruz-Rangel S; Melo Z; Vázquez N; Meade P; Bobadilla NA; Pasantes-Morales H; Gamba G; Mercado A
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C601-8. PubMed ID: 21613606
[TBL] [Abstract][Full Text] [Related]
4. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137
[TBL] [Abstract][Full Text] [Related]
6. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
7. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
Yang CL; Zhu X; Ellison DH
J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
[TBL] [Abstract][Full Text] [Related]
8. Cotransporters, WNKs and hypertension: an update.
Flatman PW
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):186-92. PubMed ID: 18277153
[TBL] [Abstract][Full Text] [Related]
9. WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1).
Leng Q; Kahle KT; Rinehart J; MacGregor GG; Wilson FH; Canessa CM; Lifton RP; Hebert SC
J Physiol; 2006 Mar; 571(Pt 2):275-86. PubMed ID: 16357011
[TBL] [Abstract][Full Text] [Related]
10. WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na+-Cl- cotransporter.
Lagnaz D; Arroyo JP; Chávez-Canales M; Vázquez N; Rizzo F; Spirlí A; Debonneville A; Staub O; Gamba G
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F275-86. PubMed ID: 24920754
[TBL] [Abstract][Full Text] [Related]
11. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis.
Rinehart J; Kahle KT; de Los Heros P; Vazquez N; Meade P; Wilson FH; Hebert SC; Gimenez I; Gamba G; Lifton RP
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16777-82. PubMed ID: 16275913
[TBL] [Abstract][Full Text] [Related]
12. WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family.
Pacheco-Alvarez D; Vázquez N; Castañeda-Bueno M; de-Los-Heros P; Cortes-González C; Moreno E; Meade P; Bobadilla NA; Gamba G
Cell Physiol Biochem; 2012; 29(1-2):291-302. PubMed ID: 22415098
[TBL] [Abstract][Full Text] [Related]
13. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases.
Ponce-Coria J; San-Cristobal P; Kahle KT; Vazquez N; Pacheco-Alvarez D; de Los Heros P; Juárez P; Muñoz E; Michel G; Bobadilla NA; Gimenez I; Lifton RP; Hebert SC; Gamba G
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8458-63. PubMed ID: 18550832
[TBL] [Abstract][Full Text] [Related]
14. Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC).
Dimke H
Pflugers Arch; 2011 Dec; 462(6):767-77. PubMed ID: 21927811
[TBL] [Abstract][Full Text] [Related]
15. WNKs are potassium-sensitive kinases.
Pleinis JM; Norrell L; Akella R; Humphreys JM; He H; Sun Q; Zhang F; Sosa-Pagan J; Morrison DE; Schellinger JN; Jackson LK; Goldsmith EJ; Rodan AR
Am J Physiol Cell Physiol; 2021 May; 320(5):C703-C721. PubMed ID: 33439774
[TBL] [Abstract][Full Text] [Related]
16. With no lysine L-WNK1 isoforms are negative regulators of the K+-Cl- cotransporters.
Mercado A; de Los Heros P; Melo Z; Chávez-Canales M; Murillo-de-Ozores AR; Moreno E; Bazúa-Valenti S; Vázquez N; Hadchouel J; Gamba G
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C54-66. PubMed ID: 27170636
[TBL] [Abstract][Full Text] [Related]
17. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
19. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
[TBL] [Abstract][Full Text] [Related]
20. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
Vitari AC; Deak M; Morrice NA; Alessi DR
Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
